North Potomac, MD, United States of America

Mark D Adams


Average Co-Inventor Count = 3.5

ph-index = 15

Forward Citations = 560(Granted Patents)


Inventors with similar research interests:


Location History:

  • Potomac, MD (US) (1996 - 2003)
  • N. Potomac, MD (US) (1997 - 2003)
  • North Potomac, MD (US) (1996 - 2006)
  • Rockville, MD (US) (2003 - 2007)
  • Cleveland Heights, OH (US) (2006 - 2010)

Company Filing History:


Years Active: 1996-2010

Loading Chart...
Areas of Expertise:
Myeloid Progenitor Inhibitory Factor-1
Human Chemokine Beta-9
Osteoclast Derived Cathepsin
Antibodies to MCP-4
Human DNA Mismatch Repair Proteins
Connective Tissue Growth Factor-2
Haemophilus Influenzae Genome
Human Growth Hormone
Transforming Growth Factor Alpha
Human Oxalyl-CoA Decarboxylase
Thrombin Inhibitor
Human Hematopoietic Maturation Factor
84 patents (USPTO):Explore Patents

Title: The Innovator Mark D Adams: Pioneering Discoveries in Biomedical Science

Introduction:

Mark D Adams, a distinguished inventor in the field of biomedical science, hails from North Potomac, MD (US). With an impressive portfolio of 84 patents, Adams has made significant contributions to the field of molecular biology and therapeutics.

Latest Patents:

Among his recent groundbreaking patents is the development of Myeloid Progenitor Inhibitory Factor-1 (MPIF-1) polypeptides. These therapeutic compositions and methods utilize isolated nucleic acid molecules encoding human MPIF-1 polypeptide, as well as antibodies to MPIF-1. These inventions have paved the way for innovative treatment approaches in immunology and oncology.

Career Highlights:

Adams has held pivotal roles at esteemed companies such as Human Genome Sciences, Inc., where his ingenuity and expertise have led to novel discoveries in the realm of biotechnology. His relentless pursuit of scientific advancement has garnered him recognition as a trailblazer in the field.

Collaborations:

Throughout his illustrious career, Adams has worked alongside esteemed colleagues such as Craig A Rosen and Haodong Li. These collaborative efforts have fostered a culture of innovation and knowledge exchange, leading to the development of cutting-edge solutions in molecular therapeutics.

Conclusion:

In conclusion, Mark D Adams stands as a beacon of innovation in the realm of biomedical science, with a rich tapestry of patents and inventions that have shaped the landscape of modern medicine. His relentless pursuit of scientific excellence and collaborative spirit have cemented his legacy as a pioneer in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…